Screening for Monoclonal Gammopathy of Undetermined Significance: A Population-Based Randomized Clinical Trial. First Results from the Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) Study
Blood (2021) 138 (Supplement 1): 156.
Currently there are no citedby results. Try again later.
